Upstream Bio (UPB) Other Operating Expenses (2024 - 2026)

Upstream Bio's Other Operating Expenses history runs 3 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

• In Q1 2026, Other Operating Expenses fell 5.6% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$4.6 million (down 77.37% YoY), while the FY2025 annual figure was -$4.5 million, down 127.77% from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$1.1 million, up from -$1.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was -$334000.0 in Q2 2024, with the low at -$1.3 million in Q4 2025.
• The 3-year median for Other Operating Expenses is -$891000.0 (2025), against an average of -$843666.7.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses tumbled 273.95% in 2025, then dropped 5.6% in 2026.
• Upstream Bio's Other Operating Expenses stood at -$836000.0 in 2024, then tumbled by 56.58% to -$1.3 million in 2025, then climbed by 14.97% to -$1.1 million in 2026.
• Business Quant data shows UPB's Other Operating Expenses at -$1.1 million in Q1 2026, -$1.3 million in Q4 2025, and -$891000.0 in Q3 2025.